Viewing Study NCT05245994


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-27 @ 11:22 PM
Study NCT ID: NCT05245994
Status: UNKNOWN
Last Update Posted: 2022-02-18
First Post: 2022-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese
Sponsor: Li Zhang, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
None Small Cell Lung Cancer View
None Durvalumab View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ES-SCLC View
None Durvalumab View
None Olaparib View